Morgan Stanley - Jun 30, 2025 SCHEDULE 13G/A Report for Taysha Gene Therapies, Inc. Common Stock (TSHA)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Taysha Gene Therapies, Inc. Common Stock
Symbol
TSHA
Shares outstanding
252M shares
Disclosed Ownership
16.9M shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Date filed
8/6/2025, 02:13 PM
Date of event
Jun 30, 2025
Previous filing
Feb 5, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 6.7% 16.9M 0 16.7M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 5.6% 14.1M 0 14.1M Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC